Skip to main content
. 2015 Sep 4;10:109. doi: 10.1186/s13023-015-0326-6

Fig. 2.

Fig. 2

Effect of patisiran on wild-type and mutant TTR in patients with the Val30Met mutation. a All post-dose data. b Patisiran 300 mg/kg groups (error bars represent SEM). Q3W: every 3 weeks; Q4W: every 4 weeks; SEM: standard error of the mean; TTR: transthyretin; wt: wild-type